<h1 itemprop="aspect"> <strong>Combivent Side Effects</strong></h1><div class="thumbnail-div"> <img src="data:image/webp;base64,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" class="attachment-84x84 wp-post-image" alt="Combivent" title="Combivent" pagespeed_url_hash="85859203" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><h2>Serious Adverse Side Effects</h2> <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> has some serious adverse side effects associated with it, such as:<ul><li>Cardiovascular side effects such as abnormal heartbeats, <a href="http://www.mayoclinic.com/health/myocardial-ischemia/DS01179">myocardial ischemia</a> (imbalance between heart oxygen supply and demand), and <a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001235/">supraventricular tachycardia</a> (rapid heart rates that originate at the ventricles of the heart)</li><li>Immunological side effects such as <a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001847/">anaphylaxis</a>, a deadly allergic reaction</li><li>Ophthalmic side effects such as <a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002587/">angle-closure glaucoma</a> (damage to the nerves in the eyes)</li><li>Respiratory side effects such as pneumonia</li><li>Other side effects such as <a href="http://en.wikipedia.org/wiki/Angioedema">angioedema</a> (a deadly allergic reaction that involves swelling of the skin and face)</li></ul><h2>Common Adverse Side Effects</h2> More common and less severe adverse side effects of <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> are:<ul><li>Neurological side effects such as headache</li><li>Respiratory side effects such as bronchitis, cough, disorders of the respiratory system, shortness of breath, throat inflammation, sinus inflammation and upper respiratory tract infection</li></ul></div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for Combivent </strong></h2><h2>Contraindications</h2> <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> has contraindications to it that hinder a patient’s ability to take this drug.  They include:<ul><li>Hypersensitivity to <strong>Ipratropium bromide</strong>, <strong>albuterol</strong>, <strong>atropine</strong> or any other derivatives or components of this drug</li><li>Hypersensitivity to soya lecithin or related soy-based food products</li></ul><h2>Who Should Not Take This Drug</h2> The following patients who have these preexisting conditions shouldn’t take this drug:<ul><li>Bladder neck obstruction</li><li>Cardiovascular disorders</li><li>Concurrent use with MAO inhibitors</li><li>Convulsive disorders</li><li>Diabetes mellitus</li><li>Excessive responses to sympathomimetic amines</li><li>Excessive use</li><li>Glaucoma</li><li>Hyperthyroidism</li><li>Hypokalemia</li><li>Prostatic hyperplasia</li></ul></div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> Combivent Treatment and Use </strong></h2><div class="thumbnail-div"> <img src="data:image/webp;base64,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" class="attachment-84x84 wp-post-image" alt="Combivent" title="Combivent" pagespeed_url_hash="85859203" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><p><strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol </strong>is a drug combination that is used to alleviate wheezing, difficulty with breathing, coughing and chest tightness in patients with <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001153/">chronic obstructive pulmonary disease</a>, or COPD.  This drug is used by COPD patients whose symptoms haven’t been controlled by single-inhaled medications.  The drug classification of <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> is that of a <a target="_blank" href="http://en.wikipedia.org/wiki/Bronchodilator">bronchodilator</a>.  This drug combination comes in the form of MDI, or <a target="_blank" href="http://en.wikipedia.org/wiki/Metered_dose_inhaler">metered-dose inhaler</a>, or as a <a target="_blank" href="http://en.wikipedia.org/wiki/Nebuliser">nebulizer</a>.  Its non-FDA labeled indication is for treatment with <a target="_blank" href="http://www.nhlbi.nih.gov/health/health-topics/topics/asthma/">asthma</a> patients.</p><p>Currently this drug is marketed and manufactured by <a target="_blank" href="http://www.boehringer-ingelheim.com/">Boehringer-Ingelheim</a>.  In the <a target="_blank" href="http://www.evaluatepharma.com/Universal/View.aspx?type=Entity&amp;entityType=Product&amp;id=10748&amp;lType=modData&amp;componentID=1002">fiscal years of 2009-10</a>, <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> had a total revenue of close to $960 billion worldwide.</p><h2>How This Drug Works</h2><p>The mechanism of action for <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> is that this has a dual action due to the formulation of two separate bronchodilators.  <strong>Ipratropium bromide </strong>is a bronchodilator known for being an <a target="_blank" href="http://www.thoracic.org/clinical/copd-guidelines/for-patients/what-kind-of-medications-are-there-for-copd/what-are-anticholinergic-medications.php">anti-cholinergic</a> while <strong>albuterol</strong> is a <a target="_blank" href="http://www.mayoclinic.com/health/drug-information/DR602095">beta-2 adrenergic</a> bronchodilator.</p><p><strong>Ipratropium bromide</strong> acts against <a target="_blank" href="http://www.chemistryexplained.com/A-Ar/Acetylcholine.html#b">acetylcholine</a> by the inhibition of reflexes in the lungs and also prevents it from binding to certain receptors of bronchial smooth muscles resulting in breath alleviation and relaxation of these muscles.</p><p><strong>Albuterol</strong> relaxes these bronchial smooth muscles by the activation of beta-2 adrenergic receptors that are present in the lung, thereby increasing intracellular concentration of <a target="_blank" href="http://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate">cyclic AMP</a> levels which activates <a target="_blank" href="http://en.wikipedia.org/wiki/Protein_kinase_A">protein kinase A</a> and the blockage of <a target="_blank" href="http://en.wikipedia.org/wiki/Phosphorylation">phosphorylation</a> of <a target="_blank" href="http://www.rpi.edu/dept/bcbp/molbiochem/MBWeb/mb2/part1/myosin.htm">myosin</a>.  This leads to the suppression of intracellular concentrations of <a target="_blank" href="http://medical-dictionary.thefreedictionary.com/Ca%2B%2B">Ca++</a> whose decrease leads to bronchial smooth muscle relaxation from the trachea to terminal bronchioles.  The added benefit of <strong>albuterol</strong> is that by increasing cyclic AMP levels, it thereby blocks the release of cells called <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed/9354811">mast cells</a> which in turn cause <a target="_blank" href="http://www.normalbreathing.com/d/bronchoconstriction.php#.UFk8AI1lR5s">bronchoconstriction</a>.</p><h2>Dosage Information</h2><p>The dosage information for <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> depends upon the severity of each patient’s COPD and asthma problems.  This drug combination is available as an inhaler and also as a nebulizer.  The starting dose for <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> is about two inhalations 4 times in a day.  Patients are able to administer a higher number of inhalations per day, however shouldn&#8217;t exceed 12 inhalations per day as anything beyond this number of inhalations hasn’t had an established effectiveness or safety profile.</p><p>Things to know before inhaling <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> are:</p><ul><li>This drug should be test-sprayed at least 3 times into the air prior to first use.</li><li>For the effective dosage, the inhaler should be shaken for about 10 seconds before each spray</li><li>COPD and asthma patients should inhale <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong> into the lungs rather than swallowing this drug into the stomach</li><li>For the proper administration of <strong>Combivent </strong><strong>|</strong> <strong>ipratropium bromide/albuterol</strong>, patients should be given adequate training before inhaling the spray.  The best practice for this drug is to hold the breath for at least 10 seconds between each spray so the maximum dosage can be absorbed into the lungs</li><li>For the most effectiveness, patients should allow 2 minute intervals between each spray</li></ul></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for Combivent</h2><h2>Brand Names</h2><br/><ul><br/><li>Combivent</li><br/><li>DuoNeb</li><br/><li>Breva</li><br/><li>Duolin</li><br/></ul><br/><h2>Generic Name</h2><br/><ul><br/><li>Ipratropium Bromide / Albuterol</li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for Combivent </strong></h2>